Curran, Desmond
Doherty, T. Mark
Lecrenier, Nicolas
Breuer, Thomas
Funding for this research was provided by:
GlaxoSmithKline Biologicals SA
Article History
Received: 20 June 2023
Accepted: 12 October 2023
First Online: 28 November 2023
Competing interests
: D.C., M.D., N.L. and T.B. are employed by/hold shares in GSK. N.L. received grants and declared patents from GSK. All authors declare no other financial and non-financial relationships and activities.